# Application and Research of Mesenchymal Stem Cells in Alleviating Severe Development of COVID-19 Infection

> **NCT05741099** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Hebei Medical University** · enrollment: 20 (estimated)

## Conditions studied

- COVID-19

## Interventions

- **BIOLOGICAL:** Umbilical cord mesenchymal stem cells implantation
- **OTHER:** Comparator

## Key facts

- **NCT ID:** NCT05741099
- **Lead sponsor:** Hebei Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-01-28
- **Primary completion:** 2024-01
- **Final completion:** 2025-01
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2023-02-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05741099

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05741099, "Application and Research of Mesenchymal Stem Cells in Alleviating Severe Development of COVID-19 Infection". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05741099. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*